O'Dell Group’s NeoGenomics NEO Stock Holding History

O'Dell Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,750	Closed	-$28.3K	–	345
2023 Q4	$28.3K	Buy	+1,750	New	+$28.6K	0.01%	260
2023 Q3	–	Sell	-1,750	Closed	-$28.1K	–	333
2023 Q2	$28.1K	Buy	+1,750	New	+$28.8K	0.01%	249
2022 Q4	–	Sell	-1,750	Closed	-$15K	–	287
2022 Q3	$15K	Sell	1,750 -750	-30%	-$7.45K	0.01%	255
2022 Q2	$20K	Sell	2,500 -1,320	-35%	-$12.6K	0.01%	225
2022 Q1	$46K	Hold	3,820	–	–	0.01%	183
2021 Q4	$130K	Hold	3,820	–	–	0.04%	98
2021 Q3	$184K	Buy	+3,820	New	+$177K	0.06%	76
2021 Q1	–	Sell	-3,820	Closed	-$206K	–	75
2020 Q4	$206K	Buy	+3,820	New	+$173K	0.08%	61

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

O'Dell Group's NEO Position: Q1 2024 in Review

O'Dell Group sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 1,750 shares — an estimated $28.3K sold.

O'Dell Group first reported a position in NEO in Q4 2020 and held it in 8 quarters. The position peaked at $206K in Q4 2020. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

O'Dell Group reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
O'Dell Group sold 1,750 NeoGenomics shares in Q1 2024, an estimated $28.3K.
O'Dell Group first reported a position in NeoGenomics in Q4 2020 and held it in 8 quarters.
O'Dell Group's NeoGenomics position peaked at $206K in Q4 2020.
263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.